Delivery Order SPE2DB20D1102-SPE2DB25FC6QP
- Not listed
- The Defense Logistics Agency (DLA) awarded a $1,713.12 delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Testosterone Cypionate 2,000 mg/10mL vials. This competitively awarded, non-set-aside contract features firm fixed pricing and a delivery completion date of August 6, 2025. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a single transaction under the company's broader...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,569.66 for Testosterone Cypionate 200 mg/mL on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed-price, competitively awarded delivery order represents a continuation of pharmaceutical supply services to support federal medical procurement needs. The contract was not issued under any set-aside program and will be performed at the contractor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,404.76 to AmerisourceBergen Drug Corp for the supply of Testosterone Cypionate 1,000 mg/10 mL (10 mL vials). This non-set-aside contract was executed on August 5, 2025, with an ultimate completion date of August 6, 2025, utilizing firm fixed-price terms. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,925.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Testosterone Cypionate 200 mg/mL on April 22, 2025, with completion targeted for April 23, 2025. This is a competitively awarded, non-set-aside contract with performance in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,259.36 to AmerisourceBergen Drug Corp for the supply of Testosterone Cypionate 200 mg/mL on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order valued at $1,723.61 to AmerisourceBergen Drug Corp for the supply of Testosterone Cypionate 200 mg/mL. This firm fixed-price, non-set-aside contract was awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,528.26 to AmerisourceBergen Drug Corp for the supply of Testosterone Cypionate 200 mg/mL on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order valued at $1,619.00 to AmerisourceBergen Drug Corp for the supply of Testosterone Cypionate 200 mg/mL. This firm fixed-price, competitively awarded delivery order was issued on July 18, 2025, with an ultimate completion date of July 21, 2025. AmerisourceBergen will perform this contract from its corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation, indicating it was awarded through open...
- The Defense Logistics Agency awarded a $1,030.88 delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Testosterone Cypionate 200 mg/mL. This firm fixed price, non-set-aside contract will be fulfilled at the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 25, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $1,783.91 to AmerisourceBergen Drug Corp for Testosterone Cypionate 200 mg/mL, with an ultimate completion date of September 16, 2025. This is a firm fixed price contract with no set-aside designation, performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a competitive procurement under the company's existing contract vehicle with DLA. This delivery order is issued under AmerisourceBergen Drug...
- SPE2DB20D1102Indefinite Delivery Contract
- SPE2DB20D1102-SPE2DB25FC6QPDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,761.52 on July 22, 2025, for the supply of Testosterone Cypionate 2,000 mg/10mL vials. This firm fixed-price delivery order, which is not set-aside designated, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. The award represents a single-item pharmaceutical procurement supporting military healthcare supply requirements through DLA's medical procurement operations. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp serves as a critical federal vendor supplying a comprehensive range of medications, vaccines, and medical supplies across multiple therapeutic domains to support military and veteran healthcare systems. The company's IDC enables flexible fulfillment of pharmaceutical needs to the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities on a global basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 7/22/25 |